209 related articles for article (PubMed ID: 9129012)
1. Lack of expression of Thy-1 (CD90) on acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo.
Blair A; Hogge DE; Ailles LE; Lansdorp PM; Sutherland HJ
Blood; 1997 May; 89(9):3104-12. PubMed ID: 9129012
[TBL] [Abstract][Full Text] [Related]
2. Most acute myeloid leukemia progenitor cells with long-term proliferative ability in vitro and in vivo have the phenotype CD34(+)/CD71(-)/HLA-DR-.
Blair A; Hogge DE; Sutherland HJ
Blood; 1998 Dec; 92(11):4325-35. PubMed ID: 9834239
[TBL] [Abstract][Full Text] [Related]
3. Primitive acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo lack surface expression of c-kit (CD117).
Blair A; Sutherland HJ
Exp Hematol; 2000 Jun; 28(6):660-71. PubMed ID: 10880752
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Thy-1 (CDw90) expression in CD34+ acute leukemia.
Holden JT; Geller RB; Farhi DC; Holland HK; Stempora LL; Phillips CN; Bray RA
Blood; 1995 Jul; 86(1):60-5. PubMed ID: 7540889
[TBL] [Abstract][Full Text] [Related]
5. Primitive AML progenitors from most CD34(+) patients lack CD33 expression but progenitors from many CD34(-) AML patients express CD33.
Vercauteren S; Zapf R; Sutherland H
Cytotherapy; 2007; 9(2):194-204. PubMed ID: 17453971
[TBL] [Abstract][Full Text] [Related]
6. Leukemic burden in subpopulations of CD34+ cells isolated from the mobilized peripheral blood of alpha-interferon-resistant or -intolerant patients with chronic myeloid leukemia.
Van den Berg D; Wessman M; Murray L; Tong J; Chen B; Chen S; Simonetti D; King J; Yamasaki G; DiGiusto R; Gearing D; Reading C
Blood; 1996 May; 87(10):4348-57. PubMed ID: 8639795
[TBL] [Abstract][Full Text] [Related]
7. Enrichment of human hematopoietic stem cell activity in the CD34+Thy-1+Lin- subpopulation from mobilized peripheral blood.
Murray L; Chen B; Galy A; Chen S; Tushinski R; Uchida N; Negrin R; Tricot G; Jagannath S; Vesole D
Blood; 1995 Jan; 85(2):368-78. PubMed ID: 7529060
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a hierarchy in human acute myeloid leukemia progenitor cells.
Sutherland HJ; Blair A; Zapf RW
Blood; 1996 Jun; 87(11):4754-61. PubMed ID: 8639846
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric analysis of Thy-1 expression in CD34-positive acute leukemia.
Inaba T; Shimazaki C; Sumikuma T; Takahashi R; Hirai H; Kikuta T; Sudo Y; Yamagata N; Ashihara E; Goto H; Fujita N; Yoshimura M; Nakagawa M
Int J Hematol; 1997 Oct; 66(3):315-23. PubMed ID: 9401277
[TBL] [Abstract][Full Text] [Related]
10. CD133 (AC133) expression on AML cells and progenitors.
Vercauteren SM; Sutherland HJ
Cytotherapy; 2001; 3(6):449-59. PubMed ID: 11953029
[TBL] [Abstract][Full Text] [Related]
11. Expression of CD90, CD96, CD117, and CD123 on different hematopoietic cell populations from pediatric patients with acute myeloid leukemia.
Chávez-González A; Dorantes-Acosta E; Moreno-Lorenzana D; Alvarado-Moreno A; Arriaga-Pizano L; Mayani H
Arch Med Res; 2014 May; 45(4):343-50. PubMed ID: 24751333
[TBL] [Abstract][Full Text] [Related]
12. Long-term leukemia-initiating capacity of a CD34-subpopulation of acute myeloid leukemia.
Terpstra W; Prins A; Ploemacher RE; Wognum BW; Wagemaker G; Löwenberg B; Wielenga JJ
Blood; 1996 Mar; 87(6):2187-94. PubMed ID: 8630378
[TBL] [Abstract][Full Text] [Related]
13. CD34+ cells from mobilized peripheral blood retain fetal bone marrow repopulating capacity within the Thy-1+ subset following cell division ex vivo.
Young JC; Lin K; Hansteen G; Travis M; Murray LJ; Jaing L; Scollay R; Hill BL
Exp Hematol; 1999 Jun; 27(6):994-1003. PubMed ID: 10378888
[TBL] [Abstract][Full Text] [Related]
14. Phenotype and function of human hematopoietic cells engrafting immune-deficient CB17-severe combined immunodeficiency mice and nonobese diabetic-severe combined immunodeficiency mice after transplantation of human cord blood mononuclear cells.
Pflumio F; Izac B; Katz A; Shultz LD; Vainchenker W; Coulombel L
Blood; 1996 Nov; 88(10):3731-40. PubMed ID: 8916937
[TBL] [Abstract][Full Text] [Related]
15. Primitive human hematopoietic cells displaying differential efflux of the rhodamine 123 dye have distinct biological activities.
Uchida N; Combs J; Chen S; Zanjani E; Hoffman R; Tsukamoto A
Blood; 1996 Aug; 88(4):1297-305. PubMed ID: 8695847
[TBL] [Abstract][Full Text] [Related]
16. Detection of cytogenetic aberrations both in CD90 (Thy-1)-positive and (Thy-1)-negative stem cell (CD34) subfractions of patients with acute and chronic myeloid leukemias.
Brendel C; Mohr B; Schimmelpfennig C; Müller J; Bornhäuser M; Schmidt M; Ritter M; Ehninger G; Neubauer A
Leukemia; 1999 Nov; 13(11):1770-5. PubMed ID: 10557051
[TBL] [Abstract][Full Text] [Related]
17. Identification of variables determining the engraftment potential of human acute myeloid leukemia in the immunodeficient NOD/SCID human chimera model.
Rombouts WJ; Martens AC; Ploemacher RE
Leukemia; 2000 May; 14(5):889-97. PubMed ID: 10803522
[TBL] [Abstract][Full Text] [Related]
18. Thy-1 expression on blast cells from adult patients with acute myeloid leukemia.
Kozii R; Wilson J; Persichetti J; Phelps V; Ball SE; Ball ED
Leuk Res; 1997 May; 21(5):381-5. PubMed ID: 9225063
[TBL] [Abstract][Full Text] [Related]
19. Dissociation between stem cell phenotype and NOD/SCID repopulating activity in human peripheral blood CD34(+) cells after ex vivo expansion.
Danet GH; Lee HW; Luongo JL; Simon MC; Bonnet DA
Exp Hematol; 2001 Dec; 29(12):1465-73. PubMed ID: 11750106
[TBL] [Abstract][Full Text] [Related]
20. Delineation of T-progenitor cell activity within the CD34+ compartment of adult bone marrow.
Galy AH; Cen D; Travis M; Chen S; Chen BP
Blood; 1995 May; 85(10):2770-8. PubMed ID: 7537981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]